Global COVID-19 Vaccine Rollout Is a Lopsided Effort – TIME

by | Nov 21, 2022 | COVID-19

As successful as the COVID-19 vaccines have been in curbing the pandemic, their benefits haven’t been enjoyed equally by people around the globe. Throughout the pandemic—and even now—vaccine development and distribution has been undeniably lopsided, skewed in favor of developed countries with the resources to create, test, manufacture, and distribute shots when the need arises. In the third year of pandemic, while nearly 70% of people worldwide have received at least one COVID-19 vaccine dose, in low-income countries, only 24% have. In its latest report on the global vaccine market, which includes an assessment of vaccines against COVID-19 and a variety of infectious diseases, the World Health Organization (WHO) calls upon both governments and companies to reshape the vaccine market to equalize these discrepancies. Pulling from the lessons learned from the global COVID-19 response, the report urges governments to invest more aggressively in the development and manufacturing of vaccines against infectious diseases—even in the absence of an existing public-health threat—focusing specifically on pursuing innovative technologies that could streamline and reduce the cost of shots. The idea is to build a more local network of scientists and manufacturers who can create and distribute a new vaccine during a crisis. But governments can’t accomplish that alone. Companies should create new pathways for sharing intellectual prope …

Article Attribution | Read More at Article Source

Share This